Sumitomo Pharma Co.Ltd.
4506Drug Manufacturers - Specialty & Generic
¥1,945.00+0.31%As of Oct 29vs prior close
- Market cap
- $5.5B
- P/E (TTM)
- 8.0×
- P/E (FY1)
- 9.0×
- From 52W high
- −38.91%
- EPS (LTM)
- ¥244.57
- Revenue (LTM)
- ¥474.8B
- Net margin
- 22.51%
Nomior Score
45
Steady ProfileBottom 39% of the scored universe
Growth47
Quality54
Value58
Momentum42
Resilience38
Growth
−6.56%revenue a year over 3 fiscal years
YE23 ¥555.5BLTM ¥474.8B
Connections
Revenue to profitYE26
24% of revenue became net profit, up 18 pts on a year.